Learn / IMMX
NASDAQ: IMMX
Immix Biopharma (IMMX) stock, explained like you're 5
Immix Biopharma trades on the Nasdaq under the ticker IMMX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 784 million dollars.
- Ticker
- IMMX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 784 million dollars
Is Immix Biopharma a small, medium or large cap company?
No. Immix Biopharma is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 784 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Immix Biopharma makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves IMMX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- How IMMX Group (IMMX) Affects Rotational Strategy Timing (Stock Traders Daily)
- Immix Biopharma (Nasdaq:IMMX) Stock Analysis (Simply Wall Street)
- IMMX Oct 2026 12.500 put (IMMX261016P00012500) Stock Historical Prices & Data Yahoo Finance (Yahoo! Finance Canada)
- All 25 new patients had a complete response or tested negative for remaining disease (Stock Titan)
- IMMX Forecast Price Target Prediction for 2027 (TradingView)
Follow IMMX in your daily brief
Each trading day at 5 PM ET we post what happened to Immix Biopharma and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow IMMX
Questions about Immix Biopharma stock
What does Immix Biopharma do?
Immix Biopharma trades on the Nasdaq under the ticker IMMX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 784 million dollars.
What is the ticker symbol for Immix Biopharma?
Immix Biopharma trades under the ticker IMMX on the Nasdaq.
What is Immix Biopharma's market cap?
Immix Biopharma is a small cap stock with a market cap of about 784 million dollars.
How does Immix Biopharma make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves IMMX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow IMMX stock every day?
Add IMMX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.